The annual general meeting (AGM) of Ascendis Health Limited held today via electronic communication saw shareholders overwhelmingly supporting all proposed resolutions.
| Resolutions | Shares Voted (%) | Votes For (%) | Votes Against (%) | Shares Abstained (%) |
|---|---|---|---|---|
| Appointment of Auditors | 57.77% | 94.44% | 5.56% | 9.86% |
| Re-election of Amaresh Chetty | 67.47% | 96.36% | 3.64% | 0.16% |
| Re-election of Lawrence Mulaudzi (Withdrawn) | N/A | N/A | N/A | N/A |
| Appointment of Amaresh Chetty to Audit Committee | 67.63% | 96.37% | 3.63% | 0.002% |
| Appointment of Dr. Karsten Wellner to Audit Committee | 67.63% | 80.67% | 19.33% | 0.002% |
| Appointment of Bharti Harie to Audit Committee | 67.63% | 95.36% | 4.64% | 0.002% |
| General Authority to Issue Shares for Cash | 67.63% | 76.90% | 23.10% | 0.002% |
| Endorsement of Remuneration Policy | 57.77% | 94.17% | 5.83% | 9.86% |
| Endorsement of Remuneration Implementation Report | 57.77% | 94.16% | 5.84% | 9.86% |
| Approval of Non-Executive Directors’ Remuneration | 57.77% | 95.48% | 4.52% | 9.86% |
| Approval of Financial Assistance (Section 44 of the Act) | 67.47% | 77.94% | 22.06% | 0.16% |
| Approval of Financial Assistance (Section 45 of the Act) | 67.47% | 80.63% | 19.37% | 0.16% |
| General Authority to Repurchase Shares | 57.61% | 94.60% | 5.40% | 10.02% |
The withdrawal of resolution number 3, pertaining to the re-election of Lawrence Mulaudzi, marked a notable shift.
Mr. Lawrence Mulaudzi, no longer an independent non-executive director, bids farewell as a key figure in Ascendis Health.
The board extends gratitude to Mr. Lawrence Mulaudzi for his valuable contributions and wishes him success in future endeavors.
In adherence to JSE Limited Listings Requirements, Mr. Mulaudzi’s departure induces changes in Ascendis Health’s board composition.
With 67.63% of total shares voted, Ascendis Health applauds shareholder engagement and commitment to corporate governance.
Valeo Capital (Pty) Limited, as the sponsor, played a vital role in facilitating the AGM and ensuring compliance with regulatory requirements.
Ascendis Health positions itself for strategic moves, buoyed by shareholder confidence and a reshaped board, ready to navigate evolving market dynamics.
This website uses cookies.
